Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
By Region: Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa
Read the resource How To Store and Get Rid of Your Home Medical Sharps for information about choosing a sharps container and disposing of your used syringes and other home medical sharps
PA involves protected health information on every transaction
The absence of a well-documented interaction does not prove that a combination is safe
Rare but serious effects include pancreatitis, gallbladder problems, and severe allergic reactions, which require immediate medical attention